HIF1A and neoplasm: Further, more knowledge on HIF-1 pathway inhibitors, including strategies targeting miRNAs (Medina and Slack, 2009) such as miR-210, might help to outwit tumor cells by removing the driving force of evolutionary pressure (Semenza, 2003; Lu and Kang, 2010; Wilczynski et al., 2011).